| Literature DB >> 21054867 |
Takashi Miyamoto1, Takeshi Muneta, Takashi Tabuchi, Kenji Matsumoto, Hirohisa Saito, Kunikazu Tsuji, Ichiro Sekiya.
Abstract
INTRODUCTION: Synovial mesenchymal stem cells (MSCs) have high proliferative and chondrogenic potentials, and MSCs transplanted into the articular cartilage defect produce abundant extracellular matrix. Because of similarities between the articular cartilage and the intervertebral disc cartilage, synovial MSCs are a potential cell source for disc regeneration. Here, we examined the effect of intradiscal transplantation of synovial MSCs after aspiration of nucleus pulposus in rabbits.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21054867 PMCID: PMC3046513 DOI: 10.1186/ar3182
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Figure 1Cells from rabbit synovium have characteristics of MSCs. (a) Right hindlimb of GFP transgenic rabbit. (b) Colony forming cells derived from GFP transgenic rabbit synovium. (c) Differentiation potentials.
Figure 2Intradiscally injected MSCs remain in the nucleus pulposus at 24 weeks. (a) Disc in normal condition and one day after intradiscal injection of DiI-labeld syonovial MSCs into the normal disc. Macroscopic views of interbertebral discs and fluorescent microscopic views of nucleus pulposus are shown. (b) Fluorescent microscopic views for GFP and DiI synovial MSCs. Nucleus pulposus was aspirated in both groups, and synovial MSCs were intradiscally injected into the MSC group.
Figure 3Intradiscally injected MSCs maintain disc height. (a) X-ray image of normal rabbit spine for measurement of disc height index. (b) Sequential changes of disc height index after transplantation of synovial MSCs. Average percentages of the value are shown with standard deviations. **P < 0.01 between the degeneration group and the normal group or the MSC group (n = 10 at each time point) by two-factor ANOVA and Turkey-Kramer post-hoc test. (c) Disc height index at two weeks after transplantation of bone marrow or synovial MSCs. Average percentages of values with standard deviations. **P < 0.01 between the bone marrow or synovial MSC group and the degeneration group (n = 6 for each group). (d) Representative T2-weighted MR images of intervertebral discs at 2 to 24 weeks after operation.
Figure 4Intradiscally injected MSCs maintain microstructure of nucleus pulpous. (a) Macroscopic views of the sagittal section of intervertebral discs at two weeks after operation. (b) Sagittal sections with Hematoxylin-Eosin (HE) staining after operation. (c) Higher magnification of the framed area with type II collagen immunostaining.
Figure 5Synovial MSCs affect gene profile of nucleus pulposus cells in co-culture system. (a) Morphology of mono-culture of rat nucleus pulposus cells and human synovial MSCs at seven days, and co-culture of rat nucleus pulposus cells with human synovial MSCs at one and seven days. (b) Human gene profile of human synovial MSCs in mono-culture and in co-culture with rat nucleus pulposus cells. (c) Rat gene profile of rat nucleus pulposus cells in mono-culture and in co-culture with human MSCs. (d) Number of altered rat genes seven days after co-culture of rat nucleus pulposus cells with human synovial cells by duplicate of microarray analyses.
Rat genes up- and down- regulated two-fold or higher in nucleus pulposus cells co-cultured with human synovial MSCs
| Genes | Genbank | Fold change |
|---|---|---|
| Collagens | ||
| Col2a1 | [Genbank: | 10.5 |
| Col1a1 | [Genbank: | -2.3 |
| Col5a1 | [Genbank: | -7.1 |
| Col5a3 | [Genbank: | -25.3 |
| Proteoglycans | ||
| Chondroitin sulfate proteoglycan 2 | [Genbank: | 2.9 |
| Biglycan | [Genbank: | -7.6 |
| Glypican 1 | [Genbank: | -13.4 |
| Lumican | [Genbank: | -16.1 |
| Chondroitin sulfate proteoglycan 4 | [Genbank: | -18.1 |
| Tissue inhibitor of metalloproteinases | ||
| TIMP-3 | [Genbank: | 27.3 |
| TIMP-1 | [Genbank: | -2.1 |
| TIMP-2 | [Genbank: | -4.7 |
| Matrix metalloproteinases | ||
| MMP-23 | [Genbank: | -2.0 |
| MMP-16 | [Genbank: | -3.0 |
| MMP-11 | [Genbank: | -3.7 |
| MMP-14 | [Genbank: | -6.0 |
| MMP-3 | [Genbank: | -44.5 |
| MMP-13 | [Genbank: | -59.7 |
| MMP-2 | [Genbank: | -82.7 |
| Interleukin related | ||
| Nuclear factor, IL-3 regulated | [Genbank: | -2.3 |
| IL-15 | [Genbank: | -3.5 |
| IL-6 signal transducer | [Genbank: | -7.4 |
| IL-11 receptor, alpha chain 1 | [Genbank: | -9.3 |
| Tumor necrosis factor related | ||
| TNF receptor superfamily, member 1a (TNFRSF1A) | [Genbank: | -2.0 |
| TNF-α converting enzyme | [Genbank: | -2.6 |
| TNF-α induced protein 6 (TSG-6) | [Genbank: | -5.4 |
| Type 1 TNF receptor shedding aminopeptidase regulator | [Genbank: | -9.0 |
| TNF receptor superfamily, member 6 (TNFRSF6) | [Genbank: | -12.5 |
A total of 15,779 rat genes consistent with the quality criteria, genes in collagens, proteoglycans, tissue inhibitor of metalloproteinases, matrix metalloproteinases, interleukin-, and tumor necrosis factor-related genes are listed. IL, interleukin; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase; TNF, tumor necrosis factor.
Figure 6Possible mechanism of prevention for intervertebral disc degeneration by intradiscal transplantation of synovial MSCs. After aspiration of the nucleus pulposus, intervertebral disc space rapidly decreases. Synovial MSCs injected into the nucleus pulposus space promote synthesis of type II collagen for the remaining nucleus pulposus cells. Also, synovial MSCs affected the remaining nucleus pulposus cells by inhibiting expressions of degradative enzymes and inflammatory cytokines, resulting in maintaining the structure of the vertebral disc.